Cart
sales@molnova.com
AMZ30
CAS No. 1313613-09-0
AMZ30( —— )
Catalog No. M19957 CAS No. 1313613-09-0
AMZ30 is a selective inhibitor of PME-1 (IC50: 600 nM). It also reduces the demethylated form of PP2A in living cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 112 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 103 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 258 | In Stock |
|
| 100MG | 381 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAMZ30
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMZ30 is a selective inhibitor of PME-1 (IC50: 600 nM). It also reduces the demethylated form of PP2A in living cells.
-
DescriptionAMZ30 is a selective inhibitor of PME-1 (IC50: 600 nM). It also reduces the demethylated form of PP2A in living cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPME-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1313613-09-0
-
Formula Weight461.44
-
Molecular FormulaC19H12FN3O6S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 4 mg/mL
-
SMILES[O-][N+](=O)c1cccc(c1)S(=O)(=O)n1cccc1\C=C(/C#N)S(=O)(=O)c1ccc(F)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bachovchin DA et al. Discovery and optimization of sulfonyl acrylonitriles as selective covalent inhibitors of protein phosphatase methylesterase-1. J Med Chem. 2011 Jul 28;54(14):5229-36.
molnova catalog
related products
-
N-hexanoyl-L-Homoser...
N-hexanoyl-L-Homoserine lactone, a small diffusible signaling molecule, is involved in controlling gene expression, affecting cellular metabolism, and quorum sensing.
-
5,7-Dihydroxychromon...
5, 7-Dihydroxychromone isolated from DME is one of the active compounds that may contribute to regulate blood glucose levels.
-
Kobophenol A
Kobophenol A has antimicrobial, and anti-inflammatory activities, it might be a candidate for treatment of inflammatory bone diseases relevant to osteoblast cell death.
